Nrc Health (NRC) Cash from Financing Activities (2010 - 2026)

Nrc Health (NRC) has 17 years of Cash from Financing Activities data on file, last reported at -$6.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 28.7% year-over-year to -$6.9 million; the trailing twelve-month figure through Mar 2026 stood at -$17.4 million (down 86.92% YoY), and the FY2025 full-year result was -$15.8 million, up 5.52% from the prior year.
• Cash from Financing Activities slipped to -$6.9 million in Q1 2026, from -$4.1 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $6.9 million in Q2 2025 to a low of -$24.0 million in Q3 2023.
• A 5-year average of -$8.0 million and a median of -$5.9 million in 2023 frame the typical range for Cash from Financing Activities.
• Peak annual rise in Cash from Financing Activities reached 353.52% in 2025, while the deepest fall reached 77723.53% in 2025.
• Tracing NRC's Cash from Financing Activities over 5 years: stood at -$9.5 million in 2022, then surged by 46.45% to -$5.1 million in 2023, then jumped by 77.25% to -$1.2 million in 2024, then tumbled by 255.8% to -$4.1 million in 2025, then tumbled by 67.67% to -$6.9 million in 2026.
• Business Quant data shows NRC's Cash from Financing Activities at -$6.9 million in Q1 2026, -$4.1 million in Q4 2025, and -$13.2 million in Q3 2025.